Heidi Hassen
Personalreferent bei VERICEL CORPORATION
Ursprung des Netzwerks ersten Grades von Heidi Hassen
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 33 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Heidi Hassen
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Jazz Pharmaceuticals (EUSA Pharma USA), Inc.
 Jazz Pharmaceuticals (EUSA Pharma USA), Inc. BiotechnologyHealth Technology Jazz Pharmaceuticals (EUSA Pharma USA), Inc. develops and markets biopharmaceutical products. The company was founded on November 7, 1980 and is headquartered in Princeton, NJ. | Biotechnology | Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
Oscient Pharmaceuticals Corp.
 Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Chief Operating Officer | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| ESPERION THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| KERYX BIOPHARMACEUTICALS | Pharmaceuticals: Major | Director/Board Member | |
| DELCATH SYSTEMS, INC. | Medical Specialties | Chief Executive Officer Director of Finance/CFO | |
QuatRx Pharmaceuticals Co.
 QuatRx Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology QuatRx Pharmaceuticals Co. manufactures and develops therapeutic compounds. Its clinical products, ospemifene and fispemifene, treat hormone deficiencies that result from aging in women and men. The firm's preclinical program is designed to address sex steroid dependent diseases through inhibition of 17beta- hydroxysteroid dehydrogenase (HSD) enzymes. The company was founded by Robert Zerbe, Christopher Nicholas, and Stuart Dombey on November 20 2000 and is headquartered in Ann Arbor, MI. | Pharmaceuticals: Major | Founder | |
| CYMABAY THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal General Counsel General Counsel Corporate Officer/Principal | |
| MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
ActivBiotics, Inc.
 ActivBiotics, Inc. BiotechnologyHealth Technology ActivBiotics, Inc. discovers and develops pharmaceutical drugs. It provides discovery, development, and commercialization of therapies for the treatment of vascular disease, inflammation, and other high-value chronic and infectious diseases. The company was founded in 1996 and is headquartered in Lexington, MA. | Biotechnology | Chief Executive Officer | |
Metabolic Solutions Development Co. LLC
 Metabolic Solutions Development Co. LLC Pharmaceuticals: GenericHealth Technology Metabolic Solutions Development Co. LLC operates as a drug discovery and development company. It develops novel therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially insulin resistance and type 2 diabetes. The company was founded by Jerry Colca and Rolf Kletzien in 2006 and is headquartered in Kalamazoo, MI. | Pharmaceuticals: Generic | Director/Board Member | |
Edgemont Pharmaceuticals LLC
 Edgemont Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Edgemont Pharmaceuticals LLC develops and provides products for psychiatric disorders. The company was founded by Douglas A. Saltel in 2008 and is headquartered in Austin, TX. | Pharmaceuticals: Major | Director/Board Member | |
| SCYNEXIS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Connecticut College | College/University | Corporate Officer/Principal | |
| Miami University | College/University | Undergraduate Degree | |
| The Pennsylvania State University | College/University | Doctorate Degree | |
| State University of New York at Buffalo | College/University | Undergraduate Degree Doctorate Degree | |
| University of Michigan | College/University | Corporate Officer/Principal Undergraduate Degree Doctorate Degree | |
Optimer Pharmaceuticals LLC
 Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Pharmaceuticals: Major | Director/Board Member | |
Hormos Medical Oy
 Hormos Medical Oy Pharmaceuticals: MajorHealth Technology Hormos Medical Oy discovers and develops novel hormonal therapies. It provides research and development of products to treat endocrine disorders associated with aging. The company was founded by Risto Arvo Sakari Lammintausta and Lauri Kangas in 1997 and is headquartered in Turku, Finland. | Pharmaceuticals: Major | Chief Executive Officer | |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Miscellaneous Commercial Services | Director/Board Member | |
Biotechnology Association of Alabama
 Biotechnology Association of Alabama Miscellaneous Commercial ServicesCommercial Services The Biotechnology Association of Alabama is a leading advocate for the state's bioeconomy. The private company is based in Birmingham, AL. The company represents the state on a national and international stage, promoting the intellectual and innovative capital that make Alabama a premier place to invest, start, and grow in bioscience. The company was founded by Thomas P. Dooley. | Miscellaneous Commercial Services | Director/Board Member | |
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Part of Pfizer Inc., Pfizer (St. Louis) is a private company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| AKEBIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Lilly Research Center Ltd.
 Lilly Research Center Ltd. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Lilly Research Center Ltd. is a British company. | Pharmaceuticals: Major | General Counsel | |
| Parke, Davis & Co. LLC | Chairman Chief Tech/Sci/R&D Officer | ||
Nextcea, Inc.
 Nextcea, Inc. Pharmaceuticals: MajorHealth Technology Nextcea, Inc. engages in manufacturing and processing of drugs in pharmaceutical preparations. It performs customized services in support of discovery, preclinical and clinical stage research and biological therapeutic development. The company was founded by Frank Y. Hsieh in 2006 and is headquartered in Woburn, MA. | Pharmaceuticals: Major | Director/Board Member | |
| CONTRAFECT CORPORATION | Biotechnology | Chief Executive Officer | |
Inflammation Research Association, Inc.
 Inflammation Research Association, Inc. Miscellaneous Commercial ServicesCommercial Services Inflammation Research Association, Inc. engages in encouraging scientists, researchers, students, teachers and clinicians with an interest in inflammation biology. The company is headquartered in Newcastle, WA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Massachusetts Society for Medical Research, Inc. | Director/Board Member | ||
PhRMA Foundation
 PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services The PhRMA Foundation is an organization that provides awards and support to individuals pursuing higher education. The non-profit company is based in Washington. The organization's 2022 annual report highlights their activities and showcases their 2022 awardees. | Miscellaneous Commercial Services | Director/Board Member | |
| INHIBIKASE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Transcelerate Biopharma, Inc.
 Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Biotechnology | Director/Board Member | |
| Temple University School of Medicine | College/University | Corporate Officer/Principal | |
AMO Pharma Ltd.
 AMO Pharma Ltd. BiotechnologyHealth Technology AMO Pharma Ltd. engages in the development of biopharmaceutical products. It develops and identifies and advance therapies for people affected by serious and debilitating diseases, particularly rare or orphan diseases. The company was founded by Michael F. Snape on February 10, 2015 and is headquartered in Leeds, United Kingdom. | Biotechnology | Chairman | |
| Sanofi Corp. | Corporate Officer/Principal Corporate Officer/Principal | ||
Obsidian Therapeutics, Inc.
 Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | Biotechnology | Chief Executive Officer Director/Board Member | |
Combined Therapeutics, Inc.
 Combined Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Combined Therapeutics, Inc. engages in biotechnology industry group. The company was founded by Romain Micol, Robert Langer, and Dan Anderson in and is headquartered in North Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Hoffmann-La Roche Ltd.
 Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Hoffmann-La Roche Ltd. is a Canadian pharmaceutical company that manufactures drugs. The private company is based in Mississauga, Canada. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Lakes Environmental Association | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 47 |
| Vereinigtes Königreich | 3 |
| Finnland | 2 |
| Kanada | 2 |
Sektoral
| Health Technology | 35 |
| Commercial Services | 7 |
| Consumer Services | 7 |
Operativ
| Director/Board Member | 113 |
| Corporate Officer/Principal | 57 |
| President | 38 |
| Independent Dir/Board Member | 33 |
| Chief Executive Officer | 32 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| George Dunbar | 31 |
| Paul Wotton | 27 |
| Steven Gilman | 25 |
| Tim Mayleben | 18 |
| Robert Zerbe | 18 |
| Alan Rubino | 16 |
| Kevin McLaughlin | 14 |
| Harold C. Urschel | 12 |
| Ronald M. Cresswell | 12 |
| Heidi Hagen | 12 |
| Scott Durbin | 10 |
| Nelson M. Sims | 10 |
| Gerard Michel | 9 |
| Jonathan Hopper | 8 |
| Dominick Colangelo | 8 |
- Börse
- Insiders
- Heidi Hassen
- Unternehmensverbindungen
